2443767-35-7
2443767-35-7
Chemical Structure
BPR1K871
Synonym(s): DBPR114
- CAS No.: 2443767-35-7
- Formula:C25H28ClN7O2S
- Molecular Weight:526.05
IUPAC Name: 1-(3-chlorophenyl)-3-(5-(2-((7-(3-(dimethylamino)propoxy)quinazolin-4-yl)amino)ethyl)thiazol-2-yl)urea
InChIKey: MMVLETOTGHDVPQ-UHFFFAOYSA-N
SMILES: O=C(NC1=CC(Cl)=CC=C1)NC2=NC=C(S2)CCNC3=NC=NC4=C3C=CC(OCCCN(C)C)=C4
Biological Activity: BPR1K871 is a potent and selective dual FLT3/AURKA inhibitor with IC50s of 19 nM and 22 nM for FLT3 and AURKA, respectively, acts as a preclinical development candidate for anti-cancer therapy[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BPR1K871 | 99.12% | BPR1K871 is a potent and selective dual FLT3/AURKA inhibitor with IC50s of 19 nM and 22 nM for FLT3 and AURKA, respectively, acts as a preclinical development candidate for anti-cancer therapy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
